Browsing Category

Production to Prescription Podcast

8 posts

DCAT Value Chain Insights’ original podcast, Production to Prescription, featuring thought leaders with expert views on the major happenings impacting the global bio/pharmaceutical manufacturing value chain and industry performance.

Keep pace with a changing marketplace and hear from industry experts on the issues and trends that need to be on your radar.

For the 2025 podcast episode schedule, click here and for the 2026 podcast schedule click here. See below for the latest episode or get through:

  • Apple Podcast
  • Spotify Podcast

What’s Trending: ADCs: Pipelines, Products & CDMO Growth 
By

By
Sponsored by Lonza AG Antibody drug conjugates (ADCs) are a niche but growing segment in the global bio/pharmaceutical industry—both on pipeline and market basis and in the CDMO sector. What are…

Drug Launches & Approvals in 2025: The Blockbuster Contenders
By

By
Which bio/pharmaceuticals, launched or approved thus far in 2025, may be potential blockbusters (defined as drugs with sales of $1 billion or more) in the mid term, and what upcoming launches or approvals and trends should be on the industry’s radar? Matthew Arnold, Principal…

CDMOs-Injectables: Tariff Impact: Are Capacity Shifts in the Making?
By

By
Sponsored by Vetter Pharma International GmbH What will be the impact of US tariffs on CDMOs of injectables and on the decision-making of pharma companies on in-sourced/outsourced activity overall and…

Headwinds or Tailwinds: Will the Biotech Sector Rebound in 2025? 
By

By
Biotech companies are an important source for innovation and product development for larger companies and are an important customer base of CDMOs/CMOs. Capital flow in the biotech sector, an important…

Global API Outlook: Will Supply Lines Change Amid Tariff Uncertainty? 
By

By
As evolving US trade policy looms, what are the demand–supply fundamentals now in the global market for active pharmaceutical ingredients (APIs)?  A look at the demand side—size, growth rates, and…

Biomanufacturing: How are Industry Capacity & Supply Chains Trending?
By

By
What is industry capacity utilization for biomanufacturing among the major systems/platforms (mammalian, microbial, and advanced therapies, and is there too much capacity or is the market tight? Is biomanufacturing outsourcing…

Parenteral Drug Manufacturing—CDMO Outlook: A Capacity Crunch or Easing?
By

By
What is the supply and demand outlook for fill–finish capacity in the CDMO/CMO sector? Is a capacity crunch or capacity ease in the making? And how will hot-product areas, such…

Bio/Pharma Industry Outlook, Supply Chains 2025: The Year Ahead
By

By
What will be the key issues shaping bio/pharma supply chains in 2025? Looking at the impact of potential changes in US tariff and trade policy. Plus, what lies ahead in…